Shen Aling, Chen Hongwei, Chen Youqin, Lin Jiumao, Lin Wei, Liu Liya, Sferra Thomas J, Peng Jun
Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, 1 Huatuo Road, Minhou Shangjie, Fuzhou, Fujian 350122, China ; Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine, 1 Huatuo Road, Minhou Shangjie, Fuzhou, Fujian 350122, China.
Rainbow Babies & Children's Hospital, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH 44106, USA ; Postdoctoral Workstation, Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., Shangjie, Zhangzhou, Fujian 363000, China.
Evid Based Complement Alternat Med. 2014;2014:679436. doi: 10.1155/2014/679436. Epub 2014 Nov 19.
The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5-FU resistant human colorectal carcinoma cell line (HCT-8/5-FU) to evaluate the effects of PZH on multidrug resistance (MDR) and epithelial-mesenchymal transition (EMT) as well as the activation of TGF-β pathway. We found that PZH dose-dependently inhibited the viability of HCT-8/5-FU cells which were insensitive to treatment of 5-FU and ADM, demonstrating the ability of PZH to overcome chemoresistance. Furthermore, PZH increased the intercellular accumulation of Rhodamine-123 and downregulated the expression of ABCG2 in HCT-8/5-FU cells. In addition, drug resistance induced the process of EMT in HCT-8 cells as evidenced by EMT-related morphological changes and alteration in the expression of EMT-regulatory factors, which however was neutralized by PZH treatment. Moreover, PZH inhibited MDR/EMT-enhanced migration and invasion capabilities of HCT-8 cells in a dose-dependent manner and suppressed MDR-induced activation of TGF-β signaling in HCT-8/5-FU cells. Taken together, our study suggests that PZH can effectively overcome MDR and inhibit EMT in human colorectal carcinoma cells via suppression of the TGF-β pathway.
中药配方片仔癀(PZH)长期以来一直被用作癌症的民间疗法。为了阐明PZH抗癌的作用模式,在本研究中,我们使用耐5-氟尿嘧啶(5-FU)的人结肠癌细胞系(HCT-8/5-FU)来评估PZH对多药耐药性(MDR)和上皮-间质转化(EMT)以及TGF-β信号通路激活的影响。我们发现PZH剂量依赖性地抑制了对5-FU和阿霉素(ADM)治疗不敏感的HCT-8/5-FU细胞的活力,证明了PZH克服化疗耐药性的能力。此外,PZH增加了罗丹明-123在细胞间的积累,并下调了HCT-8/5-FU细胞中ABCG2的表达。另外,耐药性诱导了HCT-8细胞中的EMT过程,这通过EMT相关的形态学变化和EMT调节因子表达的改变得以证明,然而PZH处理可使其恢复正常。此外,PZH剂量依赖性地抑制了MDR/EMT增强的HCT-8细胞的迁移和侵袭能力,并抑制了MDR诱导的HCT-8/5-FU细胞中TGF-β信号的激活。综上所述,我们的研究表明PZH可以通过抑制TGF-β信号通路有效克服人结肠癌细胞中的MDR并抑制EMT。